Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
647
Frequently Asked Questions
What is Market Cap of Autolus Therapeutics plc - ADR?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Autolus Therapeutics plc - ADR market cap is $367.27M.
What is the 52-week high for Autolus Therapeutics plc - ADR?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Autolus Therapeutics plc - ADR 52 week high is $5.00 as of September 16, 2025.
What is the 52-week low for Autolus Therapeutics plc - ADR?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Autolus Therapeutics plc - ADR 52 week low is $1.11 as of September 16, 2025.
What is Autolus Therapeutics plc - ADR stock price today?
Autolus Therapeutics plc - ADR stock price today is $1.32.
What was Autolus Therapeutics plc - ADR stock price yesterday?
Autolus Therapeutics plc - ADR stock price yesterday was $1.38.
What is the PE ratio of Autolus Therapeutics plc - ADR?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Autolus Therapeutics plc - ADR’s P/E ratio is -1.61.
What is the Price-to-Book ratio of Autolus Therapeutics plc - ADR?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Autolus Therapeutics plc - ADR P/B ratio is 1.4143.
What is the 50-day moving average of Autolus Therapeutics plc - ADR?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Autolus Therapeutics plc - ADR 50-day moving average is $2.06.
How many employess does Autolus Therapeutics plc - ADR has?